54 related articles for article (PubMed ID: 33768604)
1. Generation of an iPSC line (CRICKi001-A) from an individual with a germline SMARCA4 missense mutation and autism spectrum disorder.
Devito LG; Healy L; Mohammed S; Guillemot F; Dias C
Stem Cell Res; 2021 May; 53():102304. PubMed ID: 33799280
[TBL] [Abstract][Full Text] [Related]
2. Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia.
Oshima K; Zhao J; Pérez-Durán P; Brown JA; Patiño-Galindo JA; Chu T; Quinn A; Gunning T; Belver L; Ambesi-Impiombato A; Tosello V; Wang Z; Sulis ML; Kato M; Koh K; Paganin M; Basso G; Balbin M; Nicolas C; Gastier-Foster JM; Devidas M; Loh ML; Paietta E; Tallman MS; Rowe JM; Litzow M; Minden MD; Meijerink J; Rabadan R; Ferrando A
Nat Cancer; 2020 Nov; 1(11):1113-1127. PubMed ID: 33796864
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of low-dose tipifarnib on the mTOR signaling pathway and reactive oxygen species production in HIF-1α-expressing gastric cancer cells.
Egawa N; Tanaka T; Matsufuji S; Yamada K; Ito K; Kitagawa H; Okuyama K; Kitajima Y; Noshiro H
FEBS Open Bio; 2021 May; 11(5):1465-1475. PubMed ID: 33773069
[TBL] [Abstract][Full Text] [Related]
4. Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma.
Wang C; Liao Y; He W; Zhang H; Zuo D; Liu W; Yang Z; Qiu J; Yuan Y; Li K; Zhang Y; Wang Y; Shi Y; Qiu Y; Gao S; Yuan Y; Li B
J Exp Clin Cancer Res; 2021 Mar; 40(1):113. PubMed ID: 33771199
[TBL] [Abstract][Full Text] [Related]
5. Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation.
Sun J; Zhou C; Zhao Y; Zhang X; Chen W; Zhou Q; Hu B; Gao D; Raatz L; Wang Z; Nelson PJ; Jiang Y; Ren N; Bruns CJ; Zhou H
Redox Biol; 2021 May; 41():101942. PubMed ID: 33770521
[TBL] [Abstract][Full Text] [Related]
6. Spinal ependymoma in adults: from molecular advances to new treatment perspectives.
Cerretti G; Pessina F; Franceschi E; Barresi V; Salvalaggio A; Padovan M; Manara R; Di Nunno V; Bono BC; Librizzi G; Caccese M; Scorsetti M; Maccari M; Minniti G; Navarria P; Lombardi G
Front Oncol; 2023; 13():1301179. PubMed ID: 38074692
[TBL] [Abstract][Full Text] [Related]
7. Immunoreactivity of HOXB13 in Neuroendocrine Neoplasms Is a Sensitive and Specific Marker of Rectal Well-Differentiated Neuroendocrine Tumors.
Soukup J; Manethova M; Stejskal V; Hornychova H; Cesak T; Netuka D; Ryska A; Gabalec F
Endocr Pathol; 2023 Sep; 34(3):333-341. PubMed ID: 37552455
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and Treatment of Peripheral and Cranial Nerve Tumors with Expert Recommendations: An EUropean Network for RAre CANcers (EURACAN) Initiative.
Pellerino A; Verdijk RM; Nichelli L; Andratschke NH; Idbaih A; Goldbrunner R
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046591
[TBL] [Abstract][Full Text] [Related]
9. Cauda equina neuroendocrine tumors show biological features distinct from other paragangliomas and visceral neuroendocrine tumors.
Soukup J; Manethova M; Kohout A; Soukup T; Dvorakova R; Drugda J; Vitovcova B; Gabalec F; Kaiser M; Kanta M; Kasparova P; Kozak J; Michnova L; Netuka D; Reguli S; Rychly B; Trnkova M; Vachata P; Wozniakova M; Cesak T
Virchows Arch; 2023 Feb; 482(2):325-338. PubMed ID: 36348031
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing disease.
Bockmayr M; Harnisch K; Pohl LC; Schweizer L; Mohme T; Körner M; Alawi M; Suwala AK; Dorostkar MM; Monoranu CM; Hasselblatt M; Wefers AK; Capper D; Hench J; Frank S; Richardson TE; Tran I; Liu E; Snuderl M; Engertsberger L; Benesch M; von Deimling A; Obrecht D; Mynarek M; Rutkowski S; Glatzel M; Neumann JE; Schüller U
Neuro Oncol; 2022 Oct; 24(10):1689-1699. PubMed ID: 35380708
[TBL] [Abstract][Full Text] [Related]
11. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
Rindi G; Mete O; Uccella S; Basturk O; La Rosa S; Brosens LAA; Ezzat S; de Herder WW; Klimstra DS; Papotti M; Asa SL
Endocr Pathol; 2022 Mar; 33(1):115-154. PubMed ID: 35294740
[TBL] [Abstract][Full Text] [Related]
12. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract][Full Text] [Related]
13. Cauda equina paragangliomas express HOXB13.
Bockmayr M; Körner M; Schweizer L; Schüller U
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):889-890. PubMed ID: 33768604
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of CNS paragangliomas identifies cauda equina paragangliomas as a distinct tumor entity.
Schweizer L; Thierfelder F; Thomas C; Soschinski P; Suwala A; Stichel D; Wefers AK; Wessels L; Misch M; Kim HY; Jödicke R; Teichmann D; Kaul D; Kahn J; Bockmayr M; Hasselblatt M; Younsi A; Unterberg A; Knie B; Walter J; Al Safatli D; May SA; Jödicke A; Ntoulias G; Moskopp D; Vajkoczy P; Heppner FL; Capper D; Hartmann W; Hartmann C; von Deimling A; Reuss DE; Schöler A; Koch A
Acta Neuropathol; 2020 Dec; 140(6):893-906. PubMed ID: 32926213
[TBL] [Abstract][Full Text] [Related]
15. Locally invasive giant spinal paraganglioma.
Yi Chen B; Jose Mizrahi C; Yang Y; Kavar B
J Clin Neurosci; 2020 Aug; 78():430-432. PubMed ID: 32334958
[TBL] [Abstract][Full Text] [Related]
16. The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma.
Ramani B; Gupta R; Wu J; Barreto J; Bollen AW; Tihan T; Mummaneni PV; Ames C; Clark A; Oberheim Bush NA; Butowski N; Phillips D; King BE; Bator SM; Treynor EC; Zherebitskiy V; Quinn PS; Walker JB; Pekmezci M; Sullivan DV; Hofmann JW; Sloan EA; M Chang S; Berger MS; Solomon DA; Perry A
Acta Neuropathol; 2020 Dec; 140(6):907-917. PubMed ID: 32892244
[TBL] [Abstract][Full Text] [Related]
17. Paraganglioma of the cauda equina. A case report and review of the literature.
Bak J; Olsson Y; Grimelius L; Spännare B
APMIS; 1996 Mar; 104(3):234-40. PubMed ID: 8611199
[TBL] [Abstract][Full Text] [Related]
18. Paraganglioma of the cauda equina region.
Corinaldesi R; Novegno F; Giovenali P; Lunardi T; Floris R; Lunardi P
Spine J; 2015 Mar; 15(3):e1-8. PubMed ID: 25452014
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
